|
Volumn 354, Issue 17, 2006, Pages 1856-1857
|
Aspirin to prevent gentamicin-induced hearing loss [23]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
GENTAMICIN;
PLACEBO;
ADULT;
AGED;
AUDIOLOGY;
CHINA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVELOPING COUNTRY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEALTH CARE COST;
HEARING LOSS;
HUMAN;
INFECTION;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
OTOTOXICITY;
PATIENT SELECTION;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STOMACH DISEASE;
STOMACH HEMORRHAGE;
WORLD HEALTH ORGANIZATION;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTIOXIDANTS;
ASPIRIN;
CYCLOOXYGENASE INHIBITORS;
DOUBLE-BLIND METHOD;
FEMALE;
GENTAMICINS;
HEARING LOSS;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
|
EID: 33646100740
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc053428 Document Type: Letter |
Times cited : (150)
|
References (4)
|